Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23155317 | 0.93 | PLA2G2A (0.34) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL23155227 | 0.93 | MEN1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17285617 | 0.92 | HPGD (0.39) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL25580214 | 0.89 | NPC1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL25580538 | 0.89 | NPC1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL23155304 | 0.88 | CDC14B (0.33) | NPC1HPGDRAB9ASMN1; SMN2GABRP | |
| SCHEMBL25580842 | 0.88 | NPC1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL25580334 | 0.88 | NPC1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL25580676 | 0.88 | NPC1 (0.35) | NPC1HPGDRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL23155330 | 0.88 | NPC1 (0.36) | NPC1HPGDRAB9ASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| EP-3799144-B1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2022-06-01 | — | — | EP | disclosed |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
| EP-3799144-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2021-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, SMCHD1, CXCR1 | NPC1 2344/4885HPGD 2231/4885RAB9A 2552/4885 |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, SMCHD1, CXCR1 | NPC1 2344/4885HPGD 2231/4885RAB9A 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.